Inhibition of human liver FBPase expressed in Escherichia coli BL21(DE3) using FBP as substrate in presence of PGI and G6PDH by spectrophotometric method
In vivo inhibition of gluconeogenesis in overnight-fasted obese ZDF rat assessed as reduction in blood glucose level at 50 mg/kg, po administered for 24 days followed by pyruvate challenge and measured after 30 mins on day 24 by oral pyruvate tolerance test
Antidiabetic activity in KKAy mouse assessed as reduction in fasting blood glucose level at 200 mg/kg, po administered for 26 days by glucose oxidase method relative to control
Antidiabetic activity in KKAy mouse assessed as reduction in postprandial blood glucose level at 200 mg/kg, po administered for 26 days by glucose oxidase method relative to control
Antidiabetic activity in obese ZDF rat assessed as reduction in fasting blood glucose level at 50 mg/kg, po administered for 29 days by glucose oxidase method relative to control
Antidiabetic activity in obese ZDF rat assessed as reduction in postprandial blood glucose level at 50 mg/kg, po administered for 29 days by glucose oxidase method relative to control
In vivo inhibition of gluconeogenesis in overnight-fasted diabetic KKay mouse assessed as reduction in blood glucose level at 200 mg/kg, po administered for 34 days and measured on day 34 by oral pyruvate tolerance test
In vivo inhibition of gluconeogenesis in overnight-fasted diabetic KKay mouse assessed as reduction in blood glucose level at 200 mg/kg, po administered for 34 days followed by pyruvate challenge and measured after 30 mins on day 34 by oral pyruvate tolerance test
In vivo inhibition of gluconeogenesis in overnight-fasted obese ZDF rat assessed as reduction in blood glucose level at 50 mg/kg, po administered for 24 days and measured on day 24 by oral pyruvate tolerance test
In vivo inhibition of gluconeogenesis in overnight-fasted diabetic KKay mouse assessed as reduction in mean increase rate of blood glucose level at 200 mg/kg, po administered for 34 days followed by pyruvate challenge and measured after 30 mins on day 34 by oral pyruvate tolerance test
In vivo inhibition of gluconeogenesis in overnight-fasted obese ZDF rat assessed as reduction in mean increase rate of blood glucose level at 50 mg/kg, po administered for 24 days followed by pyruvate challenge and measured after 30 mins on day 24 by oral pyruvate tolerance test